Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Charlottesville, VA
SEC filing record 1 source field available
Fiscal year end
31 December
ADIAL PHARMACEUTICALS, INC. has filed 544 SEC EDGAR filings since 16 Mar 2011

SEC filing history

Showing 126-150 of 544 matching filings.

Per page
25
Current page
6
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-507664

D filing

Filing date
14 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
06 Mar 2024
Reporting date
01 Mar 2024
Next action
Verify source filing
SC 13G File 005-90718

SC 13G filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-276496

PROSPECTUS

Filing date
25 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276496

EFFECT filing

Filing date
24 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-276496

UPLOAD filing

Filing date
19 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
18 Jan 2024
Reporting date
17 Jan 2024
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
16 Jan 2024
Reporting date
11 Jan 2024
Next action
Verify source filing
S-3 File 333-276496

REGISTRATION STATEMENT

Filing date
12 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38323

DEFINITIVE ADDITIONAL MATERIALS

Filing date
15 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-276003

REGISTRATION STATEMENT

Filing date
12 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38323

PROXY STATEMENT

Filing date
08 Dec 2023
Reporting date
11 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
29 Nov 2023
Reporting date
29 Nov 2023
Next action
Verify source filing
8-K File 001-38323

CURRENT REPORT

Filing date
28 Nov 2023
Reporting date
21 Nov 2023
Next action
Verify source filing
PRE 14A File 001-38323

PRELIMINARY PROXY STATEMENT

Filing date
24 Nov 2023
Reporting date
24 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-275397

PROSPECTUS

Filing date
20 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-275397

EFFECT filing

Filing date
16 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .